821
Views
45
CrossRef citations to date
0
Altmetric
Research Article

Effects of dexmedetomidine on cerebral blood flow in critically ill patients with or without traumatic brain injury: A prospective controlled trial

, , &
Pages 1617-1622 | Received 11 Mar 2013, Accepted 30 Jul 2013, Published online: 08 Oct 2013

References

  • Roberts DJ, Hall RI, Kramer AH, Robertson HL, Gallagher CN, Zygun DA. Sedation for critically ill adults with severe traumatic brain injury: A systematic review of randomized controlled trials. Critical Care Medicine 2011;39:2743–2751
  • Strom T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: A randomised trial. Lancet 2010;375:475–480
  • Grof TM, Bledsoe KA. Evaluating the use of dexmedetomidine in neurocritical care patients. Neurocritical Care 2010;12:356–361
  • Mirski MA, Lewin JJ 3rd, Ledroux S, Thompson C, Murakami P, Zink EK, Griswold M. Cognitive improvement during continuous sedation in critically ill, awake and responsive patients: The Acute Neurological ICU Sedation Trial (ANIST). Intensive Care Medicine 2010;36:1505–1513
  • Tang JF, Chen PL, Tang EJ, May TA, Stiver SI. Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury. Neurocritical Care 2011;15:175–181
  • Prielipp RC, Wall MH, Tobin JR, Groban L, Cannon MA, Fahey FH, Gage HD, Stump DA, James RL, Bennett J, Butterworth J. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesthesia & Analgesia 2002;95:1052–1059
  • Paris A, Mantz J, Tonner PH, Hein L, Brede M, Gressens P. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. Anesthesia & Analgesia 2006;102:456–461
  • Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. European Journal of Pharmacology 2004;502:87–97
  • Jolkkonen J, Puurunen K, Koistinaho J, Kauppinen R, Haapalinna A, Nieminen L, Sivenius J. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. European Journal of Pharmacology 1999;372:31–36
  • Chi OZ, Hunter C, Liu X, Weiss HR. The effects of dexmedetomidine on regional cerebral blood flow and oxygen consumption during severe hemorrhagic hypotension in rats. Anesthesia & Analgesia 2011;113:349–355
  • Nakano T, Okamoto H. Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats. Journal of Anesthesia 2009;23:378–384
  • Drummond JC, Dao AV, Roth DM, Cheng CR, Atwater BI, Minokadeh A, Pasco LC, Patel PM. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 2008;108:225–232
  • Ogawa Y, Iwasaki K, Aoki K, Kojima W, Kato J, Ogawa S. Dexmedetomidine weakens dynamic cerebral autoregulation as assessed by transfer function analysis and the thigh cuff method. Anesthesiology 2008;109:642–650
  • McPherson RW, Koehler RC, Kirsch JR, Traystman RJ. Intraventricular dexmedetomidine decreases cerebral blood flow during normoxia and hypoxia in dogs. Anesthesia & Analgesia 1997;84:139–147
  • Karlsson BR, Forsman M, Roald OK, Heier MS, Steen PA. Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesthesia & Analgesia 1990;71:125–129
  • Aryan HE, Box KW, Ibrahim D, Desiraju U, Ames CP. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Injury 2006;20:791–798
  • DeWitt DS, Prough DS. Traumatic cerebral vascular injury: The effects of concussive brain injury on the cerebral vasculature. Journal of Neurotrauma 2003;20:795–825
  • Chesnut RM, Marshall LF, Klauber MR, Blunt BA, Baldwin N, Eisenberg HM, Jane JA, Marmarou A, Foulkes MA. The role of secondary brain injury in determining outcome from severe head injury. Journal of Trauma 1993;34:216–222
  • Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesthesia & Analgesia 1997;85:1136–1142
  • Jaeger M, Schuhmann MU, Soehle M, Meixensberger J. Continuous assessment of cerebrovascular autoregulation after traumatic brain injury using brain tissue oxygen pressure reactivity. Critical Care Medicine 2006;34:1783–1788
  • Albayrak R, Fidan F, Unlu M, Sezer M, Degirmenci B, Acar M, Haktanir A, Yaman M. Extracranial carotid Doppler ultrasound evaluation of cerebral blood flow volume in COPD patients. Respiratory Medicine 2006;100:1826–1833
  • Farag E. Dexmedetomidine in the neurointensive care unit. Discovery Medicine 2010;9:42–45
  • Engelhard K, Werner C, Kaspar S, Mollenberg O, Blobner M, Bachl M, Kochs E. Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology 2002;96:450–457
  • Huang R, Chen Y, Yu AC, Hertz L. Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: A possible mechanism for its neuroprotective activity. Journal of Cerebral Blood Flow & Metabolism 2000;20:895–898
  • Engelhard K, Werner C, Eberspacher E, Bachl M, Blobner M, Hildt E, Hutzler P, Kochs E. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesthesia & Analgesia 2003;96:524–531
  • Sanders RD, Xu J, Shu Y, Januszewski A, Halder S, Fidalgo A, Sun P, Hossain M, Ma D, Maze M. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology 2009;110:1077–1085
  • Ho SS, Chan YL, Yeung DK, Metreweli C. Blood flow volume quantification of cerebral ischemia: Comparison of three noninvasive imaging techniques of carotid and vertebral arteries. American Journal of Roentgenology 2002;178:551–556
  • Schebesch KM, Woertgen C, Schlaier J, Brawanski A, Rothoerl RD. Doppler ultrasound measurement of blood flow volume in the extracranial internal carotid artery for evaluation of brain perfusion after aneurysmal subarachnoid hemorrhage. Neurological Research 2007;29:210–214
  • Gill RW. Measurement of blood flow by ultrasound: Accuracy and sources of error. Ultrasound in Medicine & Biology 1985;11:625–641
  • Reivich M. Arterial Pco2 and cerebral hemodynamics. American Journal of Physiology 1964;206:25–35
  • Iida H, Ohata H, Iida M, Watanabe Y, Dohi S. Direct effects of alpha1- and alpha2-adrenergic agonists on spinal and cerebral pial vessels in dogs. Anesthesiology 1999;91:479–485
  • Elvan EG, Oc B, Uzun S, Karabulut E, Coskun F, Aypar U. Dexmedetomidine and postoperative shivering in patients undergoing elective abdominal hysterectomy. European Journal of Anaesthesiology 2008;25:357–364
  • But AK, Ozgul U, Erdil F, Gulhas N, Toprak HI, Durmus M, Ersoy MO. The effects of pre-operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery. Acta Anaesthesiologica Scandinavica 2006;50:1207–1212

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.